慢性自发性疹的生物和目标合成治疗方法:系统性审查和网络元分析
Zuotao Zhao1,2, Yaqi Zheng3,4,5,6, Xiaoting Song3,4,5,6
1Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Clinical and translational allergy
|May 6, 2025
概括
奥马利祖马布和雷米布鲁丁尼布在抗胰岛素耐药慢性自发性疹 (CSU) 中表现出更高的疗效. 这项网络元分析比较了26项干预措施,没有发现治疗方法间不良事件的显著差异.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- 慢性自发性疹 (CSU) 是一种具有挑战性的疾病,通常不耐标准抗组胺治疗.
- 针对特定目标的生物和合成药物为CSU提供了新的治疗途径.
- 这些先进治疗方法的对比比较有限,需要进行系统的评估.
研究的目的:
- 进行系统审查和网络元分析.
- 为了比较生物和合成向特异性药物的相对疗效和安全性,用于抗胰岛素耐火性CSU.
主要方法:
- 搜索了PubMed,Embase,科学网和Cochrane图书馆的随机试验,直到2024年3月25日.
- 采用随机效应模型来计算95%CI的网络估计 (MD,OR).
- 评估每周疹活动评分 (UAS7),不良事件 (AE) 和严重不良事件 (SAE).
主要成果:
- 包括23个RCT (6933名参与者),比较了26个干预措施.
- 奥马利祖马布300毫克显示出比安慰剂更高的疗效 (MD -10.07).
- 雷米布鲁丁尼布 (35毫克,25毫克,10毫克) 显示出最好的整体疗效和安全性.
- 与安慰剂相比,dupilumab,fenebrutinib和rilzabrutinib也提高了疗效.与安慰剂相比,dupilumab,fenebrutinib和rilzabrutinib也提高了疗效.
- 在不同治疗方法之间没有观察到AE或SAE的显著差异.
结论:
- 建议使用奥马利祖马布300毫克和雷米布鲁丁尼布 (35毫克,25毫克,10毫克) 治疗抗胰岛素耐药性CSU.
- 这些药物为耐火性CSU患者提供了有效的治疗选择.
- 进一步的研究可能会探索新兴疗法的长期安全性和比较有效性.
相关概念视频
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...


